Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Toll-like receptor 4 knockout protects against isoproterenol-induced cardiac fibrosis: the role of autophagy.

Dong RQ, Wang ZF, Zhao C, Gu HR, Hu ZW, Xie J, Wu YQ.

J Cardiovasc Pharmacol Ther. 2015 Jan;20(1):84-92. doi: 10.1177/1074248414539564. Epub 2014 Jun 20.

PMID:
24950765
2.

Toll-like receptor 4 knockout alleviates paraquat-induced cardiomyocyte contractile dysfunction through an autophagy-dependent mechanism.

Wang S, Zhu X, Xiong L, Zhang Y, Ren J.

Toxicol Lett. 2016 Aug 22;257:11-22. doi: 10.1016/j.toxlet.2016.05.024. Epub 2016 May 28.

PMID:
27246695
3.

Toll-like receptor 4 knockout protects against anthrax lethal toxin-induced cardiac contractile dysfunction: role of autophagy.

Kandadi MR, Frankel AE, Ren J.

Br J Pharmacol. 2012 Oct;167(3):612-26. doi: 10.1111/j.1476-5381.2012.02040.x.

4.

TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury.

Yang HZ, Wang JP, Mi S, Liu HZ, Cui B, Yan HM, Yan J, Li Z, Liu H, Hua F, Lu W, Hu ZW.

Am J Pathol. 2012 Jan;180(1):275-92. doi: 10.1016/j.ajpath.2011.09.019. Epub 2011 Nov 7.

PMID:
22062220
5.

Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.

Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, Nishida M, Hiuge A, Kurata A, Kihara S, Shimomura I, Funahashi T.

Arterioscler Thromb Vasc Biol. 2008 May;28(5):863-70. doi: 10.1161/ATVBAHA.107.156687. Epub 2008 Feb 28.

6.

Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia.

Fallach R, Shainberg A, Avlas O, Fainblut M, Chepurko Y, Porat E, Hochhauser E.

J Mol Cell Cardiol. 2010 Jun;48(6):1236-44. doi: 10.1016/j.yjmcc.2010.02.020. Epub 2010 Mar 4.

PMID:
20211628
7.

Rubicon deficiency enhances cardiac autophagy and protects mice from lipopolysaccharide-induced lethality and reduction in stroke volume.

Zi Z, Song Z, Zhang S, Ye Y, Li C, Xu M, Zou Y, He L, Zhu H.

J Cardiovasc Pharmacol. 2015 Mar;65(3):252-61. doi: 10.1097/FJC.0000000000000188.

PMID:
25502307
8.

Exacerbated cardiac fibrosis induced by β-adrenergic activation in old mice due to decreased AMPK activity.

Wang J, Song Y, Li H, Shen Q, Shen J, An X, Wu J, Zhang J, Wu Y, Xiao H, Zhang Y.

Clin Exp Pharmacol Physiol. 2016 Nov;43(11):1029-1037. doi: 10.1111/1440-1681.12622.

PMID:
27389807
9.

Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation.

Wang L, Li YL, Zhang CC, Cui W, Wang X, Xia Y, Du J, Li HH.

Cardiovasc Res. 2014 Mar 1;101(3):383-92. doi: 10.1093/cvr/cvt258. Epub 2013 Nov 20.

PMID:
24259498
10.

Spironolactone decreases isoproterenol-induced ventricular fibrosis and matrix metalloproteinase-2 in rats.

Hori Y, Yoshioka K, Kanai K, Hoshi F, Itoh N, Higuchi S.

Biol Pharm Bull. 2011;34(1):61-5.

11.

Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis.

Anderson M, Moore D, Larson D.

Perfusion. 2008 Jul;23(4):231-5. doi: 10.1177/0267659108100708.

PMID:
19181756
12.

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G.

Hepatology. 2008 Oct;48(4):1224-31. doi: 10.1002/hep.22470.

PMID:
18792393
13.

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload.

Ha T, Li Y, Hua F, Ma J, Gao X, Kelley J, Zhao A, Haddad GE, Williams DL, William Browder I, Kao RL, Li C.

Cardiovasc Res. 2005 Nov 1;68(2):224-34. Epub 2005 Jun 20.

PMID:
15967420
14.

Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.

Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E, Szabo G.

Am J Physiol Gastrointest Liver Physiol. 2011 Mar;300(3):G433-41. doi: 10.1152/ajpgi.00163.2009. Epub 2011 Jan 13.

15.

Luteolin-7-diglucuronide attenuates isoproterenol-induced myocardial injury and fibrosis in mice.

Ning BB, Zhang Y, Wu DD, Cui JG, Liu L, Wang PW, Wang WJ, Zhu WL, Chen Y, Zhang T.

Acta Pharmacol Sin. 2017 Mar;38(3):331-341. doi: 10.1038/aps.2016.142. Epub 2017 Jan 23.

PMID:
28112175
16.

Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia.

Hyakkoku K, Hamanaka J, Tsuruma K, Shimazawa M, Tanaka H, Uematsu S, Akira S, Inagaki N, Nagai H, Hara H.

Neuroscience. 2010 Nov 24;171(1):258-67. doi: 10.1016/j.neuroscience.2010.08.054. Epub 2010 Sep 16.

PMID:
20804821
17.

Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.

McQueen AP, Zhang D, Hu P, Swenson L, Yang Y, Zaha VG, Hoffman JL, Yun UJ, Chakrabarti G, Wang Z, Albertine KH, Abel ED, Litwin SE.

J Mol Cell Cardiol. 2005 Dec;39(6):882-92. Epub 2005 Oct 10.

PMID:
16216265
18.

Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy.

Qi GM, Jia LX, Li YL, Li HH, Du J.

Endocrinology. 2014 Jun;155(6):2254-65. doi: 10.1210/en.2013-2011. Epub 2014 Mar 31.

PMID:
24684303
19.

PDCD5 protects against cardiac remodeling by regulating autophagy and apoptosis.

Zhang S, Li G, Fu X, Qi Y, Li M, Lu G, Hu J, Wang N, Chen Y, Bai Y, Cui M.

Biochem Biophys Res Commun. 2015 May 29;461(2):321-8. doi: 10.1016/j.bbrc.2015.04.032. Epub 2015 Apr 13.

PMID:
25881505
20.

Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice.

Li XX, Jiang DY, Huang XX, Guo SL, Yuan W, Dai HP.

Genet Mol Res. 2015 Dec 21;14(4):17391-8. doi: 10.4238/2015.December.21.8.

Supplemental Content

Support Center